Purification and characterization of fertility-associated antigen (FAA) in bovine seminal fluid.

Heparin-binding proteins (HBP) recognized by a monoclonal antibody (M1) are produced by male accessory sex glands and bind to distinct regions of ejaculated bull sperm. Immunoblots of sperm proteins probed with M1 identified HBP variants of approximately 31-, 24-, and 21.5-kDa that were associated with increased fertility of bulls. The purpose of this study was to identify the 31-kDa HBP known as fertility-associated antigen (FAA). FAA was isolated by heparin-affinity chromatography and reversed-phase high performance liquid chromatography near homogeneity. Biochemical characterization indicated that FAA was an unglycosylated, basic protein. FAA protein was detected in seminal vesicle and prostate gland homogenates, and FAA extracted from sperm membranes by treatment with hypertonic media was identical biochemically to seminal fluid-derived FAA. N-terminal sequence analysis of purified FAA yielded a 26 amino acid sequence (L K I X S F N V R S F G E S K K A G F N A M R V I V) with 73% identity to a recently identified human deoxyribonuclease (DNase) I-like protein. Two internal amino acid sequences generated from lys-C digested FAA were 85% and 92% identical to the same DNase I-like protein. In conclusion, we have identified a bovine seminal heparin-binding protein that binds to sperm and is indicative of bull fertility as being similar to the family of DNase I-like proteins. These data demonstrate the presence of a novel DNase I-like protein in bull accessory sex glands and form the groundwork for the identification of a candidate genetic marker for fertility of bulls.

[Interaction of endogenous opioid peptides with the function of the hypothalamo-hypophyseal-testicular axis]. / Interacción de los péptidos opioides endógenos con la función del eje hipotálamo-hipófisis-testículo.

Since the discovery of endogenous opioid peptides and opioid receptors in the brain, their has been considerable interest in their possible role in a variety of physiological and pharmacological processes. The endogenous opioids and opiate active substances have been clearly implicated in the regulation of male reproductive function. It has been demonstrated that opioid peptides inhibit gonadotropin and TSH secretion and enhance PRL, GH and ACTH. It is believed that opioids elicit their action at the hypothalamic level, most likely by modulating the liberation of hypothalamic releasing or inhibiting factors. In healthy male adults the endogenous opioid peptides (EOP) produce a decrease in serum levels of gonadotropins. Administration of specific opiate antagonists decreases luteinizing hormone (LH) release and increases the frequency and amplitude of the LH pulses. The effects of EOP and specific opiate antagonists are altered in some hypothalamic-hypophysis-testis axis pathologies.

Interacción de los péptidos opiodes endógenos con la función del eje hipotálamo-hipófisis-testículo / Interaction of endogenous opoid peptides with hypothalamie-hypophisis-testis axis function

A partir del aislamiento e identificación de sustancias endógenas con actividad opoide (endorfinas y encefalinas) (1), y del descubrimiento de los receptores opoides en el cerebro de mamíferos (2), numerososo estudios se han realizado con el fin de conocer el papel que estos opoides endógenos tienen en la regulación neuroendocrina del eje hipotálamo-hipófisis-gónada. Tanto los opioides endógenos como los agentes químicos con actividad opoide (morfina, heroína, metadona, análogo sintéticos de encefalinas, etc.) interfieren con la producción de las hormonas secretadas por la hipófisis; el efecto de estos opoides es inhibitorio para algunas hormonas como la LH, FSH y la TSH, mientras que para otras como la PRL, GH y ACTH estimulan su producción (3), los opoides actúan a nivel hipotalámico y suprahipotalámico modulando la secreción de factores liberadores e inhibitorios. En varones adultos sanos los péptidos opioides endógenos (POE) produce una disminución de los niveles séricos de gonadotrofinas. La administración de antagonistas específicos de los receptores opiáceos aumentan la liberación de hormona luteinizante (LH) e incrementan la freuencia y amplitud de los pulsos de LH (6). Tanto los efectos de los POE como de los antagonistas específicos de sus receptores están alterados en la diferentes patologías del eje hipotálamo-hipófisis-testículo

Restoration of normal sperm characteristics in hypoprolactinemic infertile men treated with metoclopramide and exogenous human prolactin.

We investigated the effects of induced increase in prolactin levels on spermatogenesis in 20 infertile men with hypoprolactinemia using exogenous human prolactin (hPRL) and metoclopramide. The subjects were selected from a population of 175 infertile men in whom the prevalence of hypoprolactinemia was 33.14%. Mean basal plasma prolactin was 2.79 +/- 0.62 ng.ml-1 in the infertile men and 9.57 +/- 2.14 ng.ml-1 in the normal control subjects. At the sixteenth week, mean plasma prolactin was 9.41 +/- 1.3 ng.ml-1 in subjects treated with exogenous hPRL and 5.2 +/- 0.7 ng.ml-1 in subjects treated with metoclopramide. Mean basal sperm concentration was approximately 8.8 million per milliliter in the infertile men and 41.5 million per milliliter in the normal control subjects. Mean sperm concentration was approximately 37 million per milliliter in subjects treated with exogenous hPRL, whereas the peak mean value was 23 million per milliliter in subjects treated with metoclopramide for 16 weeks. At basal conditions, the mean percentages of abnormal sperm were 66.75% +/- 14.93% and 21.36% +/- 4.78% in infertile and normal subjects, respectively. In subjects treated with exogenous hPRL and metoclopramide, the mean percentage of abnormal sperm were 24.7% and 31%, respectively, at week 16. Mean plasma prolactin, mean sperm concentration and the mean percentage of abnormal sperm were 3.3 +/- 1.4 ng.ml-1, 7 million per milliliter, and 60.5, respectively, in the infertile subjects after drug withdrawal at week 14. In normal control subjects, there was no significant difference (p = 0.01) in the plecebo effect. We therefore conclude that the low prolactin levels in this group of infertile men may be one of the primary causes of their infertility.